{"id":"NCT01960842","sponsor":"AbbVie","briefTitle":"A Study to Assess the Efficacy, Safety and Tolerability of ABT-SLV187 Monotherapy in Subjects With Advanced Parkinson's Disease (PD) and Persistent Motor Complications, Despite Optimized Treatment With Available Anti-Parkinsonian Medications","officialTitle":"An Open-Label, Single-Arm, Baseline-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of ABT-SLV187 Monotherapy in Subjects With Advanced Parkinson's Disease and Persistent Motor-Complications Despite Optimized Treatment With Available Anti-Parkinsonian Medication","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-10","primaryCompletion":"2015-03","completion":"2015-03","firstPosted":"2013-10-11","resultsPosted":"2016-04-20","lastUpdate":"2018-05-30"},"enrollment":31,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Advanced Parkinson's Disease"],"interventions":[{"type":"DRUG","name":"Levodopa-carbidopa intestinal gel","otherNames":["ABT-SLV187","LCIG"]},{"type":"DEVICE","name":"CADD-LegacyÂ® 1400 ambulatory infusion pump","otherNames":[]},{"type":"DEVICE","name":"PEG tube","otherNames":[]},{"type":"DEVICE","name":"J-tube","otherNames":[]}],"arms":[{"label":"Levodopa-Carbidopa Intestinal Gel (LCIG)","type":"EXPERIMENTAL"}],"summary":"The primary objective of this study is to measure the efficacy of ABT-SLV187 in subjects with advanced Parkinson's disease.","primaryOutcome":{"measure":"Average Daily Normalized \"Off\" Time: Change From Baseline To The Final PEG-J Visit","timeFrame":"Baseline (end of screening period) and Final PEG-J Visit (up to week 12)","effectByArm":[{"arm":"Levodopa-Carbidopa Intestinal Gel (LCIG)","deltaMin":7.37,"sd":2.263}],"pValues":[{"comp":"OG000","p":"<0.001"}]},"eligibility":{"minAge":"30 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["28725701"],"seeAlso":["http://rxabbvie.com"]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":31},"commonTop":["INCISION SITE PAIN","EXCESSIVE GRANULATION TISSUE","CONSTIPATION","DIARRHOEA","NASOPHARYNGITIS"]}}